Studies have shown that many Americans distrust the pharmaceutical industry, and the wellness industry is only growing
doi: 10.3389/fendo.2017.00098 Received 18 January 2017 Accepted 18 April 2017 Published 03 May 2017 Volume 8 - 2017 Edited by Maria Felicia Faienza, Universit degli studi di Bari Aldo Moro, Italy Reviewed by Jameela Banu, University of Texas Rio Grande Valley, USA
Men and women of all ages in the Marlboro, NJ area choose physician-led GLP-1 therapy because sustainable weight loss requires more than convenience
Key approved indications include: Type 2 diabetes mellitus management (Mounjaro) Chronic weight management in obesity or overweight with comorbidities (Zepbound) Use as adjunct to lifestyle modification (diet and exercise) It is critical to recognize that tirzepatide has no FDA approval for the treatment, prevention, or management of autoimmune diseases
This can influence several cellular functions, including insulin secretion in pancreatic islet cells, as depicted in the schematic
GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes: Role and Clinical Experience to Date
,aspect=ignore)
